EpiVax Launches Precision Cancer Immunotherapy Venture, EpiVax Oncology

PROVIDENCE, R.I., Sept. 25, 2017 -- (Healthcare Sales & Marketing Network) -- EpiVax, Inc., a leader in the fields of immunogenicity assessment, vaccine design, and immune-engineering today announced the launch of EpiVax Oncology Inc., a company focused o... Biopharmaceuticals, Personalized Medicine, Oncology EpiVax, EpiVax Oncology, epitopes, immunotherapy

Source: HSMN NewsFeed - September 25, 2017 Category: Pharmaceuticals Source Type: news